peoplePerson
Dingwei Ye
Dingwei Ye is China's leading uro-oncologist, whose department runs the Chinese arms of major prostate and bladder cancer trials.
Dingwei Ye chairs urology at FUSCC and has been an investigator on Chinese and global trials of androgen-receptor pathway inhibitors, PARP inhibitors, and enfortumab vedotin and disitamab vedotin in urothelial cancer.
Role
Professor and Chair, Department of Urology, Fudan University Shanghai Cancer Center
Institution
Specialisms
Prostate cancerBladder cancerKidney cancerUrologic surgery